Iradimed (IRMD) Change in Accured Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Change in Accured Expenses data on file, last reported at -$1.2 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 668.0% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 205.29% decrease from a year earlier, with the FY2025 full-year figure at -$554000.0, down 155.57% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.2 million, down from -$853420.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for IRMD reached as high as $789247.0 in Q3 2023 and fell as low as -$1.3 million in Q1 2023.
• Historically, Change in Accured Expenses has averaged -$59513.9 across 5 years, with a median of $36305.5 in 2022.
• On a YoY basis, Change in Accured Expenses climbed as much as 879.15% in 2023 and fell as far as 15602.45% in 2023.
• Year by year, Change in Accured Expenses stood at $318353.0 in 2022, then slumped by 208.93% to -$346787.0 in 2023, then jumped by 240.68% to $487877.0 in 2024, then sank by 274.93% to -$853420.0 in 2025, then plunged by 34.99% to -$1.2 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$1.2 million in Q1 2026, -$853420.0 in Q4 2025, and $449420.0 in Q3 2025.